BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

General merchandise was one of the few categories not to benefit from rising prices in 2023, with total industry dollar sales ...

Wolfspeed rallied due to a $750 million investment from Apollo Global Management. Find out the top 7 tax-loss stocks to sell ...

The Nigerian currency has appreciated in value against the US dollar in the Nigerian Autonomous Foreign Exchange Market ...